Reuter James Wealth Management, LLC Gilead Sciences, Inc. Transaction History
Reuter James Wealth Management, LLC
- $536 Million
- Q3 2024
A detailed history of Reuter James Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Reuter James Wealth Management, LLC holds 15,144 shares of GILD stock, worth $1.34 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
15,144
Previous 12,737
18.9%
Holding current value
$1.34 Million
Previous $873,000
45.36%
% of portfolio
0.24%
Previous 0.65%
Shares
12 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.2 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.77 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.46 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.32 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $111B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...